ATRA Atara Biotherapeutics Inc: Forvard P/S multiplikatori
Atara Biotherapeutics (ATRA) o'zining T-hujayra platformasini ishlab chiqish orqali immunofarmatsevtika sohasida global yetakchilikka intilmoqda. GURU.Markets platformasida prognoz qilingan sotuvlarga nisbatan narx koeffitsienti bozor kutganlarini namoyish etadi, bunda 20.30 joriy parametr qiymati vazifasini bajaradi. Donor usulining noyobligi emitentga sezilarli narx belgilash imkoniyatini beradi, yetakchi olimlar va tartibga soluvchi ekspertlarni saqlab qolishga qaratilgan e'tibor esa tadqiqot va ishlanmalar (R&D) yadrosining barqarorligini ta'minlaydi.
atarabio.com (ATRA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Atara Biotherapeutics|ATRA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Atara Bio|ATRA - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati ATRA|ATRA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Atara Biotherapeutics|Tezkor likvidlik koeffitsiyenti atarabio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ATRA - Sof moliyaviy natija|Kutilayotgan foyda Atara Biotherapeutics|ATRA - Kapitalizatsiyaning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Atara Bio|ATRA - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori ATRA|ATRA - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Atara Biotherapeutics|ATRA - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi atarabio.com|ATRA - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Atara Biotherapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:Atara Biotherapeutics Inc (ATRA)
Ushbu koeffitsient Atara Biotherapeutics (ATRA) kompaniyasining joriy bozor qiymatini kutilayotgan yillik daromadlar bilan solishtirib, investorlarning kelajakdagi daromadlar birligi uchun to'lashga tayyor bo'lgan premiumini o'lchaydi. Forward P/S baholashini tahlil qilish orqali bozor Yevropa farmatsevtika korporatsiyalari bilan strategik ittifoqlar va royalti to'lovlari orqali tadqiqot va ishlanmalar (R&D) xarajatlari hamda pul oqimi barqarorlashtirilgan ushbu kompaniyaning o'sish potentsialini baholaydi.
Muhim raqobatchilar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|PTGX (Protagonist Therapeutics) - Forvard narx/daromad multiplikatori|IMVT: Narxning kutilayotgan daromadga nisbati|KNSA (Kiniksa) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Grifols SA|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|CLDX (Celldex Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|Forvard P/S multiplikatori biocryst.com BCRX|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics Inc)|PHVS: Forvard P/S multiplikatori|ABCL (AbCellera Corp) - Narxning prognoz qilingan daromadga nisbati|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|precigen.com (PGEN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Pharming Group (PHAR)|NKTR - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Upstream Bio Corp - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ZBIO (Zenas Corp)|Immunome, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx GOSS (gossamerbio.com)|KALV: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Septerna, Inc. (SEPN)|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals Inc|SVRA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori RIGL|Forvard P/S multiplikatori anaptysbio.com (ANAB)|Narxning prognoz qilingan daromadga nisbati Astria Therapeutics, Inc. ATXS|ENGN (enGene Holdings Inc) - Kelajakdagi narxning daromadga nisbati|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aerovate Therapeutics Inc|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|kyvernatx.com (KYTX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TLSA|CABA (Cabaletta Bio Inc.) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori VTYX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Theratechnologies, Inc|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|ELDN - Forvard narx/daromad multiplikatori|AGEN - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Climb Bio Inc. CLYM|ZURA: Forvard P/S multiplikatori|aTyr Pharmaceuticals (ATYR) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori ADAG|IMA (Ikena Oncology, Inc.) - Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Shattuck Labs, Inc. (STTK)|EQ (equilliumbio.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|IFRX - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati XFOR|ACET: Forvard P/S multiplikatori|Celularity - Sotuvga nisbatan forvard narx|INMB (INmune Bio Corp) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Barinthus Biotherapeutics Corp|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|SABS (sabbiotherapeutics.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Akari Therapeutics Plc AKTX|ENLV - Forvard narx/daromad multiplikatori|Q32 Bio Corp - Forvard P/S multiplikatori|GOVX - Forvard P/S multiplikatori|EDSA (Edesa Biotech, Inc.) - Forvard narx/daromad multiplikatori|ibioinc.com - Sotuvga nisbatan forvard narx|CARM (Carisma Therapeutics Inc) - Forvard P/S multiplikatori|XTL Biopharmaceuticals Ltd (XTLB) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|Forvard narx/daromad multiplikatori hcwbiologics.com HCWB|Narxning prognoz qilingan daromadga nisbati Aptevo Therapeutics Inc. APVO|AIM - Forvard narx/daromad multiplikatori|ADTX: Forvard narx/daromad multiplikatori|GRI - Forvard P/S multiplikatori|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HIND|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati indaptusrx.com INDP|Forvard P/S multiplikatori SCNI|Forvard P/S multiplikatori calcimedica.com (CALI)|Affimed N.V. - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ALLK (Allakos Inc)|HOOKIPA - Forvard P/S multiplikatori|IGMS - Forvard P/S multiplikatori|iTeos Therapeutics, Inc. (ITOS) - Narxning prognoz qilingan daromadga nisbati|Ocean Biomedical Inc - Sotuvga nisbatan forvard narx|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Third Harmonic Bio Inc
